Arrowhead Pharmaceuticals, Inc. Gains 40.33%
Wed, Sep 16, 2020 at 05:30 PM
Arrowhead Pharmaceuticals, Inc. (ARWR:NASDAQ) rocketted at $47.43, a gain of 40.3%. The stock got featured on our News Catalysts scanner on Wed 16 Sep 20 at 01:11 PM in the 'MISCELLANEOUS' category. From Tue 01 Sep 20, the stock recorded 33.33% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Arrowhead Pharmaceuticals, Inc. (ARWR:NASDAQ)
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
Top 10 Gainers:
- Arrowhead Pharmaceuticals, Inc. (ARWR:NASDAQ), 40.33%
- Eastman Kodak Company (KODK:NYSE), 36.6%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 35.88%
- Myomo, Inc. (MYO:NYSEMKT), 30.63%
- Nine Energy Service, Inc. (NINE:NYSE), 29.06%
- Renren Inc. (RENN:NYSE), 28.92%
- Switchback Energy Acquisition Corporation (SBE:NYSE), 27.27%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 26.46%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 26.32%
- Heat Biologics, Inc. (HTBX:NASDAQ), 23.21%